Chest
-
Asthma PostersSESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: This study aimed to determine if the use of low dose oral corticosteroid is a safe and effective alternative treatment for children with moderate persistent asthma. ⋯ The following authors have nothing to disclose: Yadnee Estrera, Arnel Gerald Jiao, Jemaila Valles, Josy Naty VenturinaNo Product/Research Disclosure Information.
-
OSA & COPD PostersSESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: Several studies have suggested that Sleep apnea Syndrome is frequent in the elderly. In Spain, Apnea hypopnea syndrome during sleep affects 2-6% of the middle-aged population and 15-20% of individual between 70 and 100 years of age, representing millions of people in our country. Because this disease is so prevalent, it is essential to study the differential characteristics of SAHS in the elderly. Objective: Analyse the differential characteristics of sleep apnea syndrome in older patients. ⋯ The following authors have nothing to disclose: Paola Arrieta Narvaez, Eva Mañas Baena, Rosa Mirambeaux Villalona, Carolina Gotera, Carolina Jurkojc Mohremberger, Deisy Barrios Barreto, Patricia Lazo Meneses, Patricia Castro Acosta, Maria Galarza Jimenez, Maria Salazar, Sagrario Mayoralas Alises, Salvador Diaz Lobato, Esteban Perez Rodriguez, Jonathan Cámara FernándezNo Product/Research Disclosure Information.
-
Pulmonary arterial hypertension (PAH) is a progressive and devastating condition characterized by vascular cell proliferation and is associated with several metabolic derangements. We hypothesized that metabolic derangements in PAH can be detected by measuring metabolic by-products in exhaled breath. ⋯ Breathprint is different between patients with PAH and healthy control subjects. Several specific compounds, including ammonia, were elevated in the breath of patients with PAH. Exhaled ammonia levels correlated with severity of disease.
-
Tuberculosis PostersSESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: Romania still has the greatest number of tuberculosis cases from the EU countries. During 2002-2012, the incidence of tuberculosis in Romania decreased by 44% from 142.2 %000 to 79 %000. Even under these conditions, we retain the position of EU leaders in the number of TB cases. TB mortality has also decreased in this period. This study want to evaluate the incidence of tuberculosis in Romania since 2008-2012. ⋯ The following authors have nothing to disclose: Constantin Marica, Didilescu Cristian, Mihaela Tanasescu, Beatrice Mahler, Gina Ana CiolanNo Product/Research Disclosure Information.
-
Infectious Disease Case Reports Posters IISESSION TYPE: Case Report PosterPRESENTED ON: Sunday, March 23, 2014 at 01:15 PM - 02:15 PMINTRODUCTION: Neutropenia complicates the management of critically ill patients. In the absence of malignancy or chemotherapy, its etiology and manifestations can be difficult to identify and portend a poor prognosis. Presented is a case of Neutropenic Enterocolitis (NEC). ⋯ Although a rare complication of medications, neutropenia resulting in NEC is unfortunate and potentially deadly. The case demonstrates the importance of follow up laboratory evaluation by primary care physicians after initiating new pharmacologic therapy.Reference #1: Irvin JD, Viau JM. Safety profiles of the angiotensin converting enzyme inhibitors captopril and enalapril. American Journal of Medicine 1986; 81:46-50.Reference #2: Nesher L and Rolston KV. Neutropenic Enterocolitis, a Growing Concern in the Era of Widespread Use of Aggressive Chemotherapy. Clinical Infectious Disease 2013; 56: 711-717.Reference #3: Shamberger RC, Weinstein HJ, Delorey MJ, Levey RH. The medical and surgical management of typhlitis in children with acute nonlymphocytic (myelogenous) leukemia. Cancer 1986; 57:603-609DISCLOSURE: The following authors have nothing to disclose: Douglas Eddy, Joseph Guileyardo, Adan MoraNo Product/Research Disclosure Information.